Figure 1From: Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective studyInitial antibiotherapy prescribed to patients infected with Escherichia coli. A patient could receive more than one drug.Back to article page